{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:58:51Z","timestamp":1790348331116,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-026-02539-7","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:47:07Z","timestamp":1790300827000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term outcomes of transcatheter mitral valve repair in patients with cancer: a systematic review and meta-analysis"],"prefix":"10.1007","author":[{"given":"Filippo","family":"Biondi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Cadeddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Camilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Cuomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia Elena","family":"Mandoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Minghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Novo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinda","family":"Madonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"2539_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/J.JACCAO.2022.01.100","volume":"4","author":"DI Paterson","year":"2022","unstructured":"Paterson DI, Wiebe N, Cheung WY, Mackey JR, Pituskin E, Reiman A, et al. Incident cardiovascular disease among adults with cancer: a population-based cohort study. JACC CardioOncol. 2022;4:85\u201394. https:\/\/doi.org\/10.1016\/J.JACCAO.2022.01.100.","journal-title":"JACC CardioOncol"},{"key":"2539_CR2","doi-asserted-by":"publisher","first-page":"1014400","DOI":"10.3389\/FCVM.2023.1014400\/TEXT","volume":"10","author":"Z Wang","year":"2023","unstructured":"Wang Z, Fan Z, Yang L, Liu L, Sheng C, Song F, et al. Higher risk of cardiovascular mortality than cancer mortality among long-term cancer survivors. Front Cardiovasc Med. 2023;10:1014400. https:\/\/doi.org\/10.3389\/FCVM.2023.1014400\/TEXT.","journal-title":"Front Cardiovasc Med"},{"key":"2539_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/CAM4.70057","volume":"13","author":"HS Ng","year":"2024","unstructured":"Ng HS, Meng R, Marin TS, Damarell RA, Buckley E, Selvanayagam JB, et al. Cardiovascular mortality in people with cancer compared to the general population: a systematic review and meta-analysis. Cancer Med. 2024;13. https:\/\/doi.org\/10.1002\/CAM4.70057.","journal-title":"Cancer Med"},{"key":"2539_CR4","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(19)30456-5","volume":"20","author":"M Arnold","year":"1995","unstructured":"Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TML, Myklebust T\u00c5, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995\u20132014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 1995;20:1493\u2013505. https:\/\/doi.org\/10.1016\/S1470-2045(19)30456-5.","journal-title":"Lancet Oncol"},{"key":"2539_CR5","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2000","unstructured":"Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nik\u0161i\u0107 M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2000;391:1023\u201375. https:\/\/doi.org\/10.1016\/S0140-6736(17)33326-3.","journal-title":"Lancet"},{"key":"2539_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ-2023-076962","author":"J Shelton","year":"1993","unstructured":"Shelton J, Zotow E, Smith L, Johnson SA, Thomson CS, Ahmad A, et al. 25 year trends in cancer incidence and mortality among adults aged 35-69 years in the UK, 1993-2018: retrospective secondary analysis. BMJ. 1993. https:\/\/doi.org\/10.1136\/BMJ-2023-076962.","journal-title":"BMJ"},{"key":"2539_CR7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_SUPPL.E23262","author":"J Chhatwal","year":"2025","unstructured":"Chhatwal J, ElHabr A, Xiao J, Tyson C, Cao X, Raoof S, et al. A decade of progress: trends in 5-year survival across 17 cancer types. J Clin Oncol. 2025. https:\/\/doi.org\/10.1200\/JCO.2025.43.16_SUPPL.E23262.","journal-title":"J Clin Oncol"},{"key":"2539_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/J.EJCSUP.2014.03.002","volume":"12","author":"BMP Aleman","year":"2014","unstructured":"Aleman BMP, Moser EC, Nuver J, Suter TM, Maraldo MV, Specht L, et al. Cardiovascular disease after cancer therapy. EJC Suppl. 2014;12:18. https:\/\/doi.org\/10.1016\/J.EJCSUP.2014.03.002.","journal-title":"EJC Suppl"},{"key":"2539_CR9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/J.JACCAO.2025.03.008\/SUPPL_FILE\/MMC1.DOCX","volume":"7","author":"FI Mulder","year":"2025","unstructured":"Mulder FI, Horv\u00e1th-Puh\u00f3 E, van Es N, Pedersen L, B\u00fcller HR, Cronin-Fenton D, et al. Risk of cardiovascular disease in cancer survivors after systemic treatment: a population-based cohort study. JACC CardioOncol. 2025;7:360\u201378. https:\/\/doi.org\/10.1016\/J.JACCAO.2025.03.008\/SUPPL_FILE\/MMC1.DOCX.","journal-title":"JACC CardioOncol"},{"key":"2539_CR10","doi-asserted-by":"publisher","unstructured":"Chen QF, Shi S, Wang YF, Shi J, Liu C, Xu T, et al. Global, regional, and national burden of valvular heart disease, 1990 to 2021. Journal of the American Heart Association 2024;13. https:\/\/doi.org\/10.1161\/JAHA.124.037991\/SUPPL_FILE\/JAH310406-SUP-0001-DATA.","DOI":"10.1161\/JAHA.124.037991\/SUPPL_FILE\/JAH310406-SUP-0001-DATA"},{"key":"2539_CR11","doi-asserted-by":"publisher","unstructured":"Gujral DM, Lloyd G, Bhattacharyya S. Radiation-induced valvular heart disease n.d. https:\/\/doi.org\/10.1136\/heartjnl.","DOI":"10.1136\/heartjnl"},{"key":"2539_CR12","doi-asserted-by":"publisher","unstructured":"Crawford MH. Chemotherapy-induced valvular heart disease. JACC: Cardiovasc Imaging. 2016;9(3):240\u20132. https:\/\/doi.org\/10.1016\/j.jcmg.2015.07.019.","DOI":"10.1016\/j.jcmg.2015.07.019"},{"key":"2539_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2026.102690","volume":"5","author":"A Sharma","year":"2026","unstructured":"Sharma A, Tsang DC, Kumar B, Okwuosa TM. Prevalence of cardiovascular disease and risk factors among cancer patients. JACC Adv. 2026;5. https:\/\/doi.org\/10.1016\/j.jacadv.2026.102690.","journal-title":"JACC Adv"},{"key":"2539_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jaccao.2022.03.004","volume":"4","author":"NML Battisti","year":"2022","unstructured":"Battisti NML, Welch CA, Sweeting M, de Belder M, Deanfield J, Weston C, et al. Prevalence of cardiovascular disease in patients with potentially curable malignancies: a national registry dataset analysis. JACC CardioOncol. 2022;4:238\u201353. https:\/\/doi.org\/10.1016\/j.jaccao.2022.03.004.","journal-title":"JACC CardioOncol"},{"key":"2539_CR15","doi-asserted-by":"publisher","unstructured":"Hauptmann L, Autherith M, Gabler C, Jantsch C, Koschatko S, Halavina K, Heitzinger G, Dannenberg V, Demirel C, Bergler-Klein J. Valvular heart disease in Cancer patiEntS - prevAlence, Relevance, and therapeutic management - preliminary results from the CESAR study. Eur Heart J. 2025;46(Suppl 1):ehaf784.4142. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf784.4142.","DOI":"10.1093\/eurheartj\/ehaf784.4142"},{"key":"2539_CR16","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/EURHEARTJ\/EHAC244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1nde T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klei J, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43:4229\u2013361. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAC244.","journal-title":"Eur Heart J"},{"key":"2539_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2022.100190","author":"P Faggiano","year":"2023","unstructured":"Faggiano P, Lorusso R, Carugo S, Faggiano A. Heart valve team conundrum: the optimal management strategy of severe aortic stenosis in cancer patients. JACC: Advances. 2023. https:\/\/doi.org\/10.1016\/j.jacadv.2022.100190.","journal-title":"JACC: Advances"},{"key":"2539_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.641268","author":"K Marmagkiolis","year":"2021","unstructured":"Marmagkiolis K, Monlezun DJ, Cilingiroglu M, Grines C, Herrmann J, Toutouzas KP, et al. TAVR in cancer patients: comprehensive review, meta-analysis, and meta-regression. Front Cardiovasc Med. 2021. https:\/\/doi.org\/10.3389\/fcvm.2021.641268.","journal-title":"Front Cardiovasc Med"},{"key":"2539_CR19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.73442","author":"U Ahsan","year":"2024","unstructured":"Ahsan U, Naz S, Anum A, Unum A, Hamza RM, Qasim RM, et al. Outcomes and adverse effects of transcatheter aortic valve replacement (TAVR) in cancer patients: a meta-analysis. Cureus. 2024. https:\/\/doi.org\/10.7759\/cureus.73442.","journal-title":"Cureus"},{"key":"2539_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s40959-024-00256-8","author":"N Felix","year":"2024","unstructured":"Felix N, Nogueira A, Carvalho PEP, Costa TA, Tramujas L, Generoso G, et al. Outcomes of patients with active cancer after transcatheter aortic valve replacement: an updated meta-analysis. Cardiooncology. 2024. https:\/\/doi.org\/10.1186\/s40959-024-00256-8.","journal-title":"Cardiooncology"},{"key":"2539_CR21","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"JPT Higgins","year":"2020","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions. Wiley-Blackwell; 2020."},{"key":"2539_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16. https:\/\/doi.org\/10.1186\/1745-6215-8-16.\u00a0","journal-title":"Trials"},{"key":"2539_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-9","volume":"12","author":"P Guyot","year":"2012","unstructured":"Guyot P, Ades AE, Ouwens MJ, Welton NJ. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol. 2012;12.","journal-title":"BMC Med Res Methodol"},{"key":"2539_CR24","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024)","author":"JPT Higgins","year":"2024","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ. Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane; 2024."},{"key":"2539_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hr\u00f3bjartsson A, Kirkham J, J\u00fcni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Sch\u00fcnemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355.","journal-title":"BMJ"},{"key":"2539_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-026-02351-x","author":"T Joudi","year":"2026","unstructured":"Joudi T, Safdar A, Shukla N, Issa R, Majeed Z, Khorana AA, et al. Catheter-based valvular and structural interventions in cancer patients. Curr Cardiol Rep. 2026. https:\/\/doi.org\/10.1007\/s11886-026-02351-x.","journal-title":"Curr Cardiol Rep"},{"key":"2539_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRC.150.SUPPL_1.4145774","author":"T Costa","year":"2024","unstructured":"Costa T, Felix N, Clemente M, Costa B, Lima N, Guha A, et al. Abstract 4145774: clinical outcomes following transcatheter edge-to-edge mitral valve repair in cancer survivors: a systematic review and meta-analysis. Circulation. 2024. https:\/\/doi.org\/10.1161\/CIRC.150.SUPPL_1.4145774.","journal-title":"Circulation"},{"key":"2539_CR28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2509766\/SUPPL_FILE\/NEJMOA2509766_DATA-SHARING.PDF","author":"MB Leon","year":"2025","unstructured":"Leon MB, Mack MJ, Pibarot P, Hahn RT, Thourani VH, Kodali SH, et al. Transcatheter or surgical aortic-valve replacement in low-risk patients at 7 years. N Engl J Med. 2025. https:\/\/doi.org\/10.1056\/NEJMOA2509766\/SUPPL_FILE\/NEJMOA2509766_DATA-SHARING.PDF.","journal-title":"N Engl J Med"},{"key":"2539_CR29","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMOA1008232\/SUPPL_FILE\/NEJMOA1008232_DISCLOSURES.PDF","volume":"363","author":"MB Leon","year":"2010","unstructured":"Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597\u2013607. https:\/\/doi.org\/10.1056\/NEJMOA1008232\/SUPPL_FILE\/NEJMOA1008232_DISCLOSURES.PDF.","journal-title":"N Engl J Med"},{"key":"2539_CR30","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMOA1805374\/SUPPL_FILE\/NEJMOA1805374_DATA-SHARING.PDF","volume":"379","author":"J-F Obadia","year":"2018","unstructured":"Obadia J-F, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med. 2018;379:2297\u2013306. https:\/\/doi.org\/10.1056\/NEJMOA1805374\/SUPPL_FILE\/NEJMOA1805374_DATA-SHARING.PDF.","journal-title":"N Engl J Med"},{"key":"2539_CR31","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMOA1806640\/SUPPL_FILE\/NEJMOA1806640_DATA-SHARING.PDF","volume":"379","author":"GW Stone","year":"2018","unstructured":"Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018;379:2307\u201318. https:\/\/doi.org\/10.1056\/NEJMOA1806640\/SUPPL_FILE\/NEJMOA1806640_DATA-SHARING.PDF.","journal-title":"N Engl J Med"},{"key":"2539_CR32","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1016\/J.JCIN.2023.10.002\/SUPPL_FILE\/MMC1.DOCX","volume":"16","author":"F Zahr","year":"2023","unstructured":"Zahr F, Smith RL, Gillam LD, Chadderdon S, Makkar R, von Bardeleben RS, et al. 1-year outcomes from the CLASP IID randomized trial for degenerative mitral regurgitation. JACC Cardiovasc Interv. 2023;16:2803\u201316. https:\/\/doi.org\/10.1016\/J.JCIN.2023.10.002\/SUPPL_FILE\/MMC1.DOCX.","journal-title":"JACC Cardiovasc Interv"},{"key":"2539_CR33","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMOA2408739\/SUPPL_FILE\/NEJMOA2408739_DATA-SHARING.PDF","volume":"391","author":"S Baldus","year":"2024","unstructured":"Baldus S, Doenst T, Pfister R, Gummert J, Kessler M, Boekstegers P, et al. Transcatheter repair versus mitral-valve surgery for secondary mitral regurgitation. N Engl J Med. 2024;391:1787\u201398. https:\/\/doi.org\/10.1056\/NEJMOA2408739\/SUPPL_FILE\/NEJMOA2408739_DATA-SHARING.PDF.","journal-title":"N Engl J Med"},{"key":"2539_CR34","doi-asserted-by":"publisher","first-page":"344","DOI":"10.18295\/SQUMJ.1.2023.002","volume":"23","author":"RA Sakr","year":"2023","unstructured":"Sakr RA, Nasr AA, Zineldin EI, Gouda MA. Long-term survival in patients with cancers: surveillance, epidemiology and end results-based analysis. Sultan Qaboos Univ Med J. 2023;23:344. https:\/\/doi.org\/10.18295\/SQUMJ.1.2023.002.","journal-title":"Sultan Qaboos Univ Med J"},{"key":"2539_CR35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s00392-023-02266-5","volume":"113","author":"A Kalkan","year":"2024","unstructured":"Kalkan A, Metze C, Iliadis C, K\u00f6rber MI, Baldus S, Pfister R. Prognostic impact of cancer history in patients undergoing transcatheter mitral valve repair. Clin Res Cardiol. 2024;113:94\u2013106. https:\/\/doi.org\/10.1007\/s00392-023-02266-5.","journal-title":"Clin Res Cardiol"},{"key":"2539_CR36","first-page":"140","volume":"24","author":"ZA Ghosh","year":"2022","unstructured":"Ghosh ZA, Shuvy M, Beeri R, Gotsman I, Falah B, Ibrahimli M, et al. Percutaneous mitral valve repair in cancer patients with heart failure and severe mitral regurgitation. Isr Med Assoc J. 2022;24:140\u20133.","journal-title":"Isr Med Assoc J"},{"key":"2539_CR37","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s00392-020-01770-2","volume":"110","author":"N Tabata","year":"2021","unstructured":"Tabata N, Weber M, Sugiura A, \u00d6zt\u00fcrk C, Tsujita K, Nickenig G, et al. Impact of cancer history on clinical outcome in patients undergoing transcatheter edge-to-edge mitral repair. Clin Res Cardiol. 2021;110:440\u201350. https:\/\/doi.org\/10.1007\/s00392-020-01770-2.","journal-title":"Clin Res Cardiol"},{"key":"2539_CR38","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.amjcard.2020.01.047","volume":"125","author":"A Guha","year":"2020","unstructured":"Guha A, Dey AK, Omer S, Abraham WT, Attizzani G, Jneid H, et al. Contemporary trends and outcomes of percutaneous and surgical mitral valve replacement or repair in patients with cancer. Am J Cardiol. 2020;125:1355\u201360. https:\/\/doi.org\/10.1016\/j.amjcard.2020.01.047.","journal-title":"Am J Cardiol"},{"key":"2539_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2025.10.001","author":"R Gonz\u00e1lez-Manzanares","year":"2025","unstructured":"Gonz\u00e1lez-Manzanares R, Ojeda S, Carrasco-Chinchilla F, Benito-Gonz\u00e1lez T, Pascual I, Nombela-Franco L, et al. Transcatheter mitral edge-to-edge repair in patients with a prior cancer diagnosis: insights from the Spanish M-TEER registry. Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition). 2025. https:\/\/doi.org\/10.1016\/j.rec.2025.10.001.","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"key":"2539_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2022.101165","author":"S Khan","year":"2023","unstructured":"Khan S, Dani SS, Hermann J, Neilan TG, Lenihan DJ, Fradley M, et al. Safety and efficacy of transcatheter edge-to-edge repair (TEER) in patients with history of cancer. IJC Heart Vasc. 2023. https:\/\/doi.org\/10.1016\/j.ijcha.2022.101165.","journal-title":"IJC Heart Vasc"},{"key":"2539_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/1755-5922.12239","author":"A \u00d6ner","year":"2017","unstructured":"\u00d6ner A, Ince H, Paranskaya L, Schr\u00f6der G, Sherif M, Thiele O, et al. Previous malignancy is an independent predictor of follow-up mortality after percutaneous treatment of mitral valve regurgitation by means of MitraClip. Cardiovasc Ther. 2017. https:\/\/doi.org\/10.1111\/1755-5922.12239.","journal-title":"Cardiovasc Ther"},{"key":"2539_CR42","unstructured":"Predicting immediate and late outcome after surgery for mitral valve regurgitation with EuroSCORE - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/17484456\/ (accessed June 15, 2026)."},{"key":"2539_CR43","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/EJCTS\/EZAA403","volume":"59","author":"D Carino","year":"2021","unstructured":"Carino D, Denti P, Ascione G, Del Forno B, Lapenna E, Ruggeri S, et al. Is the EuroSCORE II reliable in surgical mitral valve repair? A single-centre validation study. Eur J Cardiothorac Surg. 2021;59:863\u20138. https:\/\/doi.org\/10.1093\/EJCTS\/EZAA403.","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02539-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-026-02539-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02539-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:03:12Z","timestamp":1790344992000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-026-02539-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":43,"alternative-id":["2539"],"URL":"https:\/\/doi.org\/10.1007\/s11357-026-02539-7","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"27 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests related to this work.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}